$ProKidney (PROK.US)$ From April 14 Carso De-C Inmobiliaria has made a significant investment in ProKidney by purchasing 1,034,118 shares of its stock. This transaction is valued at $620,470, highlighting a strong interest and confidence in ProKidney’s potential.
TWIMO (151403908)
:
?!?!?! such a literal company name with over 200m market capitalisation grossing under 100k only??? can’t even afford a reputable doctor. this must be a joke on the investors.
$ProKidney (PROK.US)$ ProKidney Reports Third Quarter 2024 Financial Results along with Regulatory and Clinical Development Updates Following Successful FDA Type B Meeting Positive FDA confirmation that PROACT 1 Phase 3 study could be sufficient for full regulatory approval Accelerated approval pathway available with eGFR slope as surrogate endpoint Strong cash position of $406.8 million, supporting operations into 2027 Reduced R&D expenses by $0.9 million year-over-year Slight improvement...
$ProKidney (PROK.US)$ProKidney | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Aaron Cowen(10.47%),Suvretta Capital Management, LLC(9.8%), etc. SEC· 11 mins ago
Report
No comment yet
Sign in to post a comment
Market Insights
U.S Tech Companies U.S Tech Companies
U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.
ProKidney Stock Forum
From April 14
Carso De-C Inmobiliaria has made a significant investment in ProKidney by purchasing 1,034,118 shares of its stock. This transaction is valued at $620,470, highlighting a strong interest and confidence in ProKidney’s potential.
ProKidney Reports Third Quarter 2024 Financial Results along with Regulatory and Clinical Development Updates Following Successful FDA Type B Meeting
Positive
FDA confirmation that PROACT 1 Phase 3 study could be sufficient for full regulatory approval
Accelerated approval pathway available with eGFR slope as surrogate endpoint
Strong cash position of $406.8 million, supporting operations into 2027
Reduced R&D expenses by $0.9 million year-over-year
Slight improvement...
SEC· 11 mins ago
No comment yet